We get more details on the ready-to-use technologies alliance forged between Schott Pharma, Gerresheimer, and Stevanato.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How CRISPR can change the way we design and produce antibodies.

How will the biopharma industry evolve over the next 10 years? We speak with experts from Sartorius and the USP.

PicnicHealth Co-founder and CEO Noga Leviner foresees AI as the augur of greater observational research

Alfred Marchler and Peter Hirst discuss the biggest disruptors shaping the next decade.

Developing science is good; developing successful commercialization strategies is great.

Cell therapy has come a long way since the 1930s. Next, we need to find a way to bring the costs down by using allogeneic approaches.

Voting is now open for our 2025 Company of the Year Awards.

As 3D printing gains traction in the pharma industry, its potential to revolutionize solid oral dosage forms is becoming clearer.